T80.310D ABO incompatibility with acute hemolytic transfusion reaction, subsequent encounter

Name of the Condition

• ABO incompatibility with acute hemolytic transfusion reaction, subsequent encounter.

Summary

This condition represents a subsequent encounter for an adverse immune reaction that occurs when blood or blood products with incompatible ABO antigens are transfused, leading to acute hemolysis (destruction of red blood cells). It is a serious complication that can cause systemic effects, including organ damage and hemodynamic instability. The reaction is driven by pre-existing antibodies in the recipient that target antigens on the transfused red blood cells.

Causes

ABO incompatibility reactions result from the transfusion of blood or blood products containing ABO antigens that do not match the recipient's blood type. This mismatch triggers an immune response, where the recipient's antibodies bind to the donor red blood cells, leading to their destruction (hemolysis). The reaction can occur with red blood cells, plasma, or platelets if ABO compatibility is not maintained.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Dyspnea or respiratory distress
• Jaundice or pallor
• Nausea, vomiting, or abdominal pain
• Chest or back pain
• Unexplained bleeding or coagulopathy

Diagnosis

Diagnosis involves clinical assessment of transfusion reaction symptoms, laboratory testing to confirm hemolysis (e.g., elevated bilirubin, decreased haptoglobin, hemoglobinuria), and verification of ABO incompatibility through blood typing and crossmatching. Additional tests may include direct antiglobulin test (DAT) to detect antibody-coated red blood cells and assessment of renal function to evaluate for acute kidney injury.

Treatment Options

Treatment focuses on stopping the transfusion immediately, maintaining hemodynamic stability with fluids and vasopressors, and managing hemolysis-related complications (e.g., renal support for acute kidney injury). Supportive care may include oxygen therapy, antipyretics for fever, and monitoring for disseminated intravascular coagulation (DIC). In severe cases, plasmapheresis or dialysis may be required.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Most patients recover with appropriate management, but severe cases can lead to organ failure or death. Follow-up includes monitoring for delayed complications (e.g., renal impairment) and ensuring no further incompatible transfusions occur. Long-term care may involve evaluation of underlying conditions or transfusion needs.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or multi-organ dysfunction
• Transfusion-related acute lung injury (TRALI)
• Death (in severe cases)

Lifestyle & Prevention

Prevention relies on strict adherence to blood typing, crossmatching, and verification protocols before transfusion. Patients with known antibodies or sensitivities should have their blood type and compatibility confirmed. Healthcare providers should follow standardized procedures to minimize human error in blood product administration.

When to Seek Professional Help

Seek immediate medical attention if symptoms of a transfusion reaction occur during or after a blood transfusion, including fever, chills, pain, dark urine, or difficulty breathing. Prompt evaluation is critical to prevent severe complications.

Tips for Medical Coders

Code T80.310D is used for a subsequent encounter for ABO incompatibility with acute hemolytic transfusion reaction. Document the encounter as a follow-up visit related to the reaction, and ensure the diagnosis is clearly linked to the transfusion event. Include details of the reaction's severity and any ongoing management in the medical record to support coding accuracy.